Table of Contents
1. Executive Summary
2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2014 to 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global CRISPR Market Trends and Forecast
3.3: Global CRISPR Market by Product
3.3.1: Enzymes
3.3.2: Kits
3.3.3: gRNA (Guide RNA)
3.3.4: Libraries
3.3.5: Design Tools
3.4: Global CRISPR Market by Service
3.4.1: gRNA Design
3.4.2: Cell Line Engineering
3.5: Global CRISPR Market by Application
3.5.1: Biomedical
3.5.2: Agricultural
3.5.3: Industrial
3.5.4: Biological Research
3.6: Global CRISPR Market by Species
3.6.1: Pharma & Biopharma Companies
3.6.2: Biotechnology Companies
3.6.3: Academics
3.6.4: Contract Research Organization (CROs)
4. Market Trends and Forecast Analysis by Region
4.1: Global CRISPR Market by Region
4.2: North American CRISPR Market
4.2.1: Market by Product: Enzymes, Kits, gRNA, Libraries, and Design Tools
4.2.2: Market by Service: gRNA Design and Cell Line Engineering
4.2.3: Market by Application: Biomedical, Agricultural, Industrial, and Biological Research
4.2.4: Market by End User: Pharma & Biopharma Companies, Biotechnology Companies, Academics, and Contract Research Organization
4.2.5: The United States CRISPR Market
4.2.6: The Canadian CRISPR Market
4.2.7: The Mexican CRISPR Market
4.3: European CRISPR Market
4.3.1: Market by Product: Enzymes, Kits, gRNA, Libraries, and Design Tools
4.3.2: Market by Service: gRNA Design and Cell Line Engineering
4.3.3: Market by Application: Biomedical, Agricultural, Industrial, and Biological Research
4.3.4: Market by End User: Pharma & Biopharma Companies, Biotechnology Companies, Academics, and Contract Research Organization
4.3.5: The CRISPR Market of United Kingdom
4.3.6: The German CRISPR Market
4.3.7: The French CRISPR Market
4.4: APAC CRISPR Market
4.4.1: Market by Product: Enzymes, Kits, gRNA, Libraries, and Design Tools
4.4.2: Market by Service: gRNA Design and Cell Line Engineering
4.4.3: Market by Application: Biomedical, Agricultural, Industrial, and Biological Research
4.4.4: Market by End User: Pharma & Biopharma Companies, Biotechnology Companies, Academics, and Contract Research Organization
4.4.5: The Chinese CRISPR Market
4.4.6: The Indian CRISPR Market
4.4.7: The Japanese CRISPR Market
4.5: ROW CRISPR Market
4.5.1: Market by Product: Enzymes, Kits, gRNA, Libraries, and Design Tools
4.5.2: Market by Service: gRNA Design and Cell Line Engineering
4.5.3: Market by Application: Biomedical, Agricultural, Industrial, and Biological Research
4.5.4: Market by End User: Pharma & Biopharma Companies, Biotechnology Companies, Academics, and Contract Research Organization
4.5.5: Brazilian CRISPR Market
5. Competitor Analysis
5.1: Market Share Analysis
5.2: Product Portfolio Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. Cost Structure Analysis
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. Growth Opportunities and Strategic Analysis
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global CRISPR Market by Product
7.1.2: Growth Opportunities for the Global CRISPR Market by Service
7.1.3: Growth Opportunities for the Global CRISPR Market by Application
7.1.4: Growth Opportunities for the Global CRISPR Market by End User
7.1.5: Growth Opportunities for the Global CRISPR Market by Region
7.2: Emerging Trends in the Global CRISPR Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global CRISPR Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global CRISPR Market
7.3.4: Certification and Licensing
8. Company Profiles of Leading Players
8.1: Cellecta, Inc.
8.2: Thermo Fisher
8.3: GeneCopoeia, Inc.
8.4: Applied StemCell
8.5: Synthego Corporation
8.6: OriGene Technologies
8.7: Horizon Discovery
8.8: Merck
8.9: GenScript
8.10: Company 10